Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Chemical inhibitors of cyclin-dependent kinases.

Meijer L.

Trends Cell Biol. 1996 Oct;6(10):393-7.

PMID:
15157522
2.

Cyclin E-CDK2 is a regulator of p27Kip1.

Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE.

Genes Dev. 1997 Jun 1;11(11):1464-78.

3.

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6380-5.

4.

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.

Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM.

Nat Med. 1997 Feb;3(2):222-5.

PMID:
9018243
5.
6.
7.

Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development.

Lane ME, Sauer K, Wallace K, Jan YN, Lehner CF, Vaessin H.

Cell. 1996 Dec 27;87(7):1225-35.

8.

Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.

Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin WG Jr.

Mol Cell Biol. 1996 Dec;16(12):6623-33.

9.

How proteolysis drives the cell cycle.

King RW, Deshaies RJ, Peters JM, Kirschner MW.

Science. 1996 Dec 6;274(5293):1652-9. Review.

PMID:
8939846
11.

Formation of p27-CDK complexes during the human mitotic cell cycle.

Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.

Cell Growth Differ. 1996 Feb;7(2):135-46.

12.

Cdk inhibitors in development and cancer.

Harper JW, Elledge SJ.

Curr Opin Genet Dev. 1996 Feb;6(1):56-64. Review.

PMID:
8791491
13.

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.

Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM.

Genes Dev. 1996 Aug 15;10(16):1979-90.

14.

Ubiquitin in signal transduction and cell transformation.

Isaksson A, Musti AM, Bohmann D.

Biochim Biophys Acta. 1996 Aug 8;1288(1):F21-9. Review.

PMID:
8764838
15.

Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway.

Willems AR, Lanker S, Patton EE, Craig KL, Nason TF, Mathias N, Kobayashi R, Wittenberg C, Tyers M.

Cell. 1996 Aug 9;86(3):453-63.

16.
17.

Control of gene expression by proteolysis.

Pahl HL, Baeuerle PA.

Curr Opin Cell Biol. 1996 Jun;8(3):340-7. Review.

PMID:
8743884
18.

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW, Elledge SJ.

Cell. 1996 Jul 26;86(2):263-74.

19.

Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts.

Rivard N, L'Allemain G, Bartek J, Pouysségur J.

J Biol Chem. 1996 Aug 2;271(31):18337-41.

20.

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.

Russo AA, Jeffrey PD, Patten AK, Massagué J, Pavletich NP.

Nature. 1996 Jul 25;382(6589):325-31.

PMID:
8684460

Supplemental Content

Support Center